TreeWAS – Variant ID: rs9368644

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
E03.9 Hypothyroidism, unspecified	0.000	0.000	1.000
K90.0 Coeliac disease	0.000	0.000	1.000
L40.9 Psoriasis, unspecified	1.000	0.000	0.000
L40.5 Arthropathic psoriasis	1.000	0.000	0.000
E10 Insulin-dependent diabetes mellitus	0.000	0.000	1.000
L40 Psoriasis	1.000	0.000	0.000
E00-E07 Disorders of thyroid gland	0.000	0.000	1.000
E10.9 Without complications	0.000	0.000	1.000
E05 Thyrotoxicosis [hyperthyroidism]	0.000	0.000	1.000
E03 Other hypothyroidism	0.000	0.000	1.000
E05.9 Thyrotoxicosis, unspecified	0.000	0.000	1.000
Chapter IV Endocrine, nutritional and metabolic diseases	0.000	0.002	0.998
E10-E14 Diabetes mellitus	0.000	0.002	0.998
E05.0 Thyrotoxicosis with diffuse goitre	0.000	0.009	0.991
E50-E64 Other nutritional deficiencies	0.000	0.009	0.991
L40.0 Psoriasis vulgaris	0.983	0.017	0.000
E53 Deficiency of other B group vitamins	0.000	0.019	0.981
T36-T50 Poisoning by drugs, medicaments and biological substances	0.980	0.020	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.977	0.023	0.000
E53.8 Deficiency of other specified B group vitamins	0.000	0.026	0.974
E10.3 With ophthalmic complications	0.000	0.037	0.963
E10.4 With neurological complications	0.000	0.038	0.962
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.960	0.040	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.954	0.046	0.000
T43.2 Other and unspecified antidepressants	0.946	0.054	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.946	0.054	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.934	0.066	0.000
E10.5 With peripheral circulatory complications	0.000	0.071	0.929
T50.9 Other and unspecified drugs, medicaments and biological substances	0.909	0.091	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.900	0.100	0.000
L40.1 Generalised pustular psoriasis	0.887	0.113	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.886	0.114	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.879	0.121	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.877	0.123	0.000
E06 Thyroiditis	0.000	0.129	0.871
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.865	0.135	0.000
T42.4 Benzodiazepines	0.853	0.147	0.000
T39.1 4-Aminophenol derivatives	0.853	0.147	0.000
E10.2 With renal complications	0.000	0.160	0.840
E55 Vitamin D deficiency	0.000	0.165	0.835
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.831	0.169	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.805	0.194	0.000
E06.3 Autoimmune thyroiditis	0.000	0.206	0.794
E10.6 With other specified complications	0.000	0.220	0.780
L40.8 Other psoriasis	0.775	0.225	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.775	0.225	0.000
E10.8 With unspecified complications	0.000	0.226	0.774
T43.6 Psychostimulants with abuse potential	0.772	0.227	0.000
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion	0.000	0.230	0.769
E10.0 With coma	0.000	0.248	0.751
E05.8 Other thyrotoxicosis	0.000	0.255	0.745
T46 Poisoning by agents primarily affecting the cardiovascular system	0.727	0.273	0.000
E04 Other non-toxic goitre	0.000	0.277	0.723
E55.9 Vitamin D deficiency, unspecified	0.000	0.277	0.723
E61 Deficiency of other nutrient elements	0.000	0.283	0.717
E10.7 With multiple complications	0.000	0.283	0.717
L40.4 Guttate psoriasis	0.717	0.283	0.000
L40.3 Pustulosis palmaris et plantaris	0.717	0.283	0.000
L40.2 Acrodermatitis continua	0.717	0.283	0.000
E01 Iodine-deficiency-related thyroid disorders and allied conditions	0.000	0.283	0.717
E00 Congenital iodine-deficiency syndrome	0.000	0.283	0.717
E02 Subclinical iodine-deficiency hypothyroidism	0.000	0.283	0.717
E05.5 Thyroid crisis or storm	0.000	0.283	0.717
E05.4 Thyrotoxicosis factitia	0.000	0.283	0.717
E05.3 Thyrotoxicosis from ectopic thyroid tissue	0.000	0.283	0.717
E05.1 Thyrotoxicosis with toxic single thyroid nodule	0.000	0.283	0.717
E03.5 Myxoedema coma	0.000	0.283	0.717
E03.4 Atrophy of thyroid (acquired)	0.000	0.283	0.717
E03.3 Postinfectious hypothyroidism	0.000	0.283	0.717
E03.0 Congenital hypothyroidism with diffuse goitre	0.000	0.283	0.717
E12 Malnutrition-related diabetes mellitus	0.000	0.284	0.715
E64 Sequelae of malnutrition and other nutritional deficiencies	0.000	0.290	0.710
E63 Other nutritional deficiencies	0.000	0.290	0.710
E56 Other vitamin deficiencies	0.000	0.290	0.710
E51 Thiamine deficiency	0.000	0.290	0.710
E50 Vitamin A deficiency	0.000	0.290	0.710
E60 Dietary zinc deficiency	0.000	0.290	0.710
E59 Dietary selenium deficiency	0.000	0.290	0.710
E58 Dietary calcium deficiency	0.000	0.290	0.710
E54 Ascorbic acid deficiency	0.000	0.290	0.710
E52 Niacin deficiency [pellagra]	0.000	0.290	0.710
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.709	0.291	0.000
E53.9 Vitamin B deficiency, unspecified	0.000	0.297	0.703
E53.1 Pyridoxine deficiency	0.000	0.297	0.703
E53.0 Riboflavin deficiency	0.000	0.297	0.703
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.702	0.298	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.702	0.298	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.702	0.298	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.702	0.298	0.000
T43.9 Psychotropic drug, unspecified	0.700	0.300	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.700	0.300	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.700	0.300	0.000
T36 Poisoning by systemic antibiotics	0.696	0.304	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.693	0.307	0.000
T47.0 Histamine H(2)-receptor antagonists	0.692	0.308	0.000
T39.0 Salicylates	0.690	0.310	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.688	0.312	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.688	0.312	0.000
T42.3 Barbiturates	0.688	0.312	0.000
T42.2 Succinimides and oxazolidinediones	0.688	0.312	0.000
T42.0 Hydantoin derivatives	0.688	0.312	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.684	0.316	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.684	0.316	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.684	0.316	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.684	0.316	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.684	0.316	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.684	0.316	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.684	0.316	0.000
T44.0 Anticholinesterase agents	0.684	0.316	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.682	0.318	0.000
T50.8 Diagnostic agents	0.678	0.321	0.000
T50.7 Analeptics and opioid receptor antagonists	0.678	0.321	0.000
T50.5 Appetite depressants	0.678	0.321	0.000
T50.4 Drugs affecting uric acid metabolism	0.678	0.321	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.678	0.321	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.678	0.321	0.000
T50.1 Loop [high-ceiling] diuretics	0.678	0.321	0.000
T50.0 Mineralocorticoids and their antagonists	0.678	0.321	0.000
E04.9 Non-toxic goitre, unspecified	0.000	0.325	0.675
E13 Other specified diabetes mellitus	0.000	0.335	0.665
T47.1 Other antacids and anti-gastric-secretion drugs	0.650	0.350	0.000
E03.2 Hypothyroidism due to medicaments and other exogenous substances	0.000	0.351	0.649
E03.1 Congenital hypothyroidism without goitre	0.000	0.355	0.645
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.639	0.361	0.000
E10.1 With ketoacidosis	0.000	0.368	0.632
T39.4 Antirheumatics, not elsewhere classified	0.630	0.370	0.000
T39.2 Pyrazolone derivatives	0.630	0.370	0.000
E06.5 Other chronic thyroiditis	0.000	0.375	0.624
E06.4 Drug-induced thyroiditis	0.000	0.375	0.624
E06.2 Chronic thyroiditis with transient thyrotoxicosis	0.000	0.375	0.624
E06.1 Subacute thyroiditis	0.000	0.375	0.624
E06.0 Acute thyroiditis	0.000	0.375	0.624
E07 Other disorders of thyroid	0.000	0.376	0.624
K90 Intestinal malabsorption	0.000	0.386	0.614
E16 Other disorders of pancreatic internal secretion	0.000	0.395	0.605
E03.8 Other specified hypothyroidism	0.000	0.398	0.602
T43.5 Other and unspecified antipsychotics and neuroleptics	0.600	0.400	0.000
E55.0 Rickets, active	0.000	0.401	0.599
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.596	0.404	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.596	0.404	0.000
T47.7 Emetics	0.596	0.404	0.000
T47.6 Antidiarrhoeal drugs	0.596	0.404	0.000
T47.5 Digestants	0.596	0.404	0.000
T47.4 Other laxatives	0.596	0.404	0.000
T47.3 Saline and osmotic laxatives	0.596	0.404	0.000
T47.2 Stimulant laxatives	0.596	0.404	0.000
T42.1 Iminostilbenes	0.594	0.406	0.000
T45.0 Antiallergic and antiemetic drugs	0.579	0.421	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.577	0.423	0.000
E06.9 Thyroiditis, unspecified	0.000	0.426	0.574
E40-E46 Malnutrition	0.000	0.428	0.572
E15 Nondiabetic hypoglycaemic coma	0.000	0.448	0.552
K90.9 Intestinal malabsorption, unspecified	0.000	0.449	0.551
M07.30 Other psoriatic arthropathies (Multiple sites)	0.550	0.450	0.000
M07.3 Other psoriatic arthropathies	0.544	0.456	0.000
M07.39 Other psoriatic arthropathies (Site unspecified)	0.537	0.463	0.000
E05.2 Thyrotoxicosis with toxic multinodular goitre	0.000	0.464	0.536
T38.1 Thyroid hormones and substitutes	0.529	0.471	0.000
E61.2 Magnesium deficiency	0.000	0.474	0.526
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.521	0.479	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.521	0.479	0.000
T46.7 Peripheral vasodilators	0.521	0.479	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.521	0.479	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.521	0.479	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.521	0.479	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.521	0.479	0.000
E04.8 Other specified non-toxic goitre	0.000	0.481	0.519
E04.0 Non-toxic diffuse goitre	0.000	0.483	0.517
E61.9 Deficiency of nutrient element, unspecified	0.000	0.486	0.514
E61.8 Deficiency of other specified nutrient elements	0.000	0.486	0.514
E61.7 Deficiency of multiple nutrient elements	0.000	0.486	0.514
E61.6 Vanadium deficiency	0.000	0.486	0.514
E61.5 Molybdenum deficiency	0.000	0.486	0.514
E61.4 Chromium deficiency	0.000	0.486	0.514
E61.3 Manganese deficiency	0.000	0.486	0.514
E61.0 Copper deficiency	0.000	0.486	0.514
T46.1 Calcium-channel blockers	0.514	0.486	0.000
E00.9 Congenital iodine-deficiency syndrome, unspecified	0.000	0.486	0.514
E00.2 Congenital iodine-deficiency syndrome, mixed type	0.000	0.486	0.514
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type	0.000	0.486	0.514
E00.0 Congenital iodine-deficiency syndrome, neurological type	0.000	0.486	0.514
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions	0.000	0.486	0.514
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified	0.000	0.486	0.514
E01.1 Iodine-deficiency-related multinodular (endemic) goitre	0.000	0.486	0.514
E01.0 Iodine-deficiency-related diffuse (endemic) goitre	0.000	0.486	0.514
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.514	0.486	0.000
E12.9 Without complications	0.000	0.487	0.513
E12.8 With unspecified complications	0.000	0.487	0.513
E12.7 With multiple complications	0.000	0.487	0.513
E12.6 With other specified complications	0.000	0.487	0.513
E12.5 With peripheral circulatory complications	0.000	0.487	0.513
E12.4 With neurological complications	0.000	0.487	0.513
E12.3 With ophthalmic complications	0.000	0.487	0.513
E12.2 With renal complications	0.000	0.487	0.513
E12.1 With ketoacidosis	0.000	0.487	0.513
E12.0 With coma	0.000	0.487	0.513
E50.9 Vitamin A deficiency, unspecified	0.000	0.490	0.509
E50.8 Other manifestations of vitamin A deficiency	0.000	0.490	0.509
E50.7 Other ocular manifestations of vitamin A deficiency	0.000	0.490	0.509
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea	0.000	0.490	0.509
E50.5 Vitamin A deficiency with night blindness	0.000	0.490	0.509
E50.4 Vitamin A deficiency with keratomalacia	0.000	0.490	0.509
E50.3 Vitamin A deficiency with corneal ulceration and xerosis	0.000	0.490	0.509
E50.2 Vitamin A deficiency with corneal xerosis	0.000	0.490	0.509
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis	0.000	0.490	0.509
E50.0 Vitamin A deficiency with conjunctival xerosis	0.000	0.490	0.509
E51.9 Thiamine deficiency, unspecified	0.000	0.490	0.509
E51.8 Other manifestations of thiamine deficiency	0.000	0.490	0.509
E51.2 Wernicke's encephalopathy	0.000	0.490	0.509
E51.1 Beriberi	0.000	0.490	0.509
E56.9 Vitamin deficiency, unspecified	0.000	0.490	0.509
E56.8 Deficiency of other vitamins	0.000	0.490	0.509
E56.1 Deficiency of vitamin K	0.000	0.490	0.509
E56.0 Deficiency of vitamin E	0.000	0.490	0.509
E63.9 Nutritional deficiency, unspecified	0.000	0.490	0.509
E63.8 Other specified nutritional deficiencies	0.000	0.490	0.509
E63.1 Imbalance of constituents of food intake	0.000	0.490	0.509
E63.0 Essential fatty acid [EFA] deficiency	0.000	0.490	0.509
E64.9 Sequelae of unspecified nutritional deficiency	0.000	0.490	0.509
E64.8 Sequelae of other nutritional deficiencies	0.000	0.490	0.509
E64.3 Sequelae of rickets	0.000	0.490	0.509
E64.2 Sequelae of vitamin C deficiency	0.000	0.490	0.509
E64.1 Sequelae of vitamin A deficiency	0.000	0.490	0.509
E64.0 Sequelae of protein-energy malnutrition	0.000	0.490	0.509
E61.1 Iron deficiency	0.000	0.491	0.509
T38.9 Other and unspecified hormone antagonists	0.508	0.492	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.508	0.492	0.000
T38.7 Androgens and anabolic congeners	0.508	0.492	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.508	0.492	0.000
T38.5 Other oestrogens and progestogens	0.508	0.492	0.000
T38.4 Oral contraceptives	0.508	0.492	0.000
T38.2 Antithyroid drugs	0.508	0.492	0.000
T38.0 Glucocorticoids and synthetic analogues	0.508	0.492	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.504	0.496	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.504	0.496	0.000
T37.5 Antiviral drugs	0.504	0.496	0.000
T37.4 Anthelminthics	0.504	0.496	0.000
T37.3 Other antiprotozoal drugs	0.504	0.496	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.504	0.496	0.000
T37.1 Antimycobacterial drugs	0.504	0.496	0.000
T37.0 Sulphonamides	0.504	0.496	0.000
T41.5 Therapeutic gases	0.504	0.496	0.000
T41.4 Anaesthetic, unspecified	0.504	0.496	0.000
T41.3 Local anaesthetics	0.504	0.496	0.000
T41.2 Other and unspecified general anaesthetics	0.504	0.496	0.000
T41.1 Intravenous anaesthetics	0.504	0.496	0.000
T41.0 Inhaled anaesthetics	0.504	0.496	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.504	0.496	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.504	0.496	0.000
T48.5 Anti-common-cold drugs	0.504	0.496	0.000
T48.4 Expectorants	0.504	0.496	0.000
T48.3 Antitussives	0.504	0.496	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.504	0.496	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.504	0.496	0.000
T48.0 Oxytocic drugs	0.504	0.496	0.000
T49.9 Topical agent, unspecified	0.504	0.496	0.000
T49.8 Other topical agents	0.504	0.496	0.000
T49.7 Dental drugs, topically applied	0.504	0.496	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.504	0.496	0.000
T49.5 Ophthalmological drugs and preparations	0.504	0.496	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.504	0.496	0.000
T49.3 Emollients, demulcents and protectants	0.504	0.496	0.000
T49.2 Local astringents and local detergents	0.504	0.496	0.000
T49.1 Antipruritics	0.504	0.496	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.504	0.496	0.000
T36.9 Systemic antibiotic, unspecified	0.499	0.501	0.000
T36.8 Other systemic antibiotics	0.499	0.501	0.000
T36.7 Antifungal antibiotics, systemically used	0.499	0.501	0.000
T36.6 Rifamycins	0.499	0.501	0.000
T36.5 Aminoglycosides	0.499	0.501	0.000
T36.4 Tetracyclines	0.499	0.501	0.000
T36.3 Macrolides	0.499	0.501	0.000
T36.2 Chloramphenicol group	0.499	0.501	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.499	0.501	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.497	0.503	0.000
T45.8 Other primarily systemic and haematological agents	0.497	0.503	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.497	0.503	0.000
T45.6 Fibrinolysis-affecting drugs	0.497	0.503	0.000
T45.4 Iron and its compounds	0.497	0.503	0.000
T45.3 Enzymes, not elsewhere classified	0.497	0.503	0.000
T45.2 Vitamins, not elsewhere classified	0.497	0.503	0.000
T36.0 Penicillins	0.493	0.507	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.493	0.507	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.486	0.513	0.000
E13.8 With unspecified complications	0.000	0.523	0.477
E13.7 With multiple complications	0.000	0.523	0.477
E13.6 With other specified complications	0.000	0.523	0.477
E13.5 With peripheral circulatory complications	0.000	0.523	0.477
E13.4 With neurological complications	0.000	0.523	0.477
E13.3 With ophthalmic complications	0.000	0.523	0.477
E13.2 With renal complications	0.000	0.523	0.477
E13.1 With ketoacidosis	0.000	0.523	0.477
E13.0 With coma	0.000	0.523	0.477
E16.2 Hypoglycaemia, unspecified	0.000	0.529	0.471
E07.9 Disorder of thyroid, unspecified	0.000	0.530	0.470
M07.36 Other psoriatic arthropathies (Lower leg)	0.457	0.543	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.452	0.547	0.000
E16.0 Drug-induced hypoglycaemia without coma	0.000	0.550	0.450
E07.1 Dyshormogenetic goitre	0.000	0.553	0.447
E07.0 Hypersecretion of calcitonin	0.000	0.553	0.447
M07.34 Other psoriatic arthropathies (Hand)	0.441	0.559	0.000
K90.3 Pancreatic steatorrhoea	0.000	0.559	0.440
K90.2 Blind loop syndrome, not elsewhere classified	0.000	0.559	0.440
K90.1 Tropical sprue	0.000	0.559	0.440
E16.1 Other hypoglycaemia	0.000	0.560	0.439
E16.9 Disorder of pancreatic internal secretion, unspecified	0.000	0.566	0.434
E16.8 Other specified disorders of pancreatic internal secretion	0.000	0.566	0.434
E16.4 Abnormal secretion of gastrin	0.000	0.566	0.434
E16.3 Increased secretion of glucagon	0.000	0.566	0.434
E13.9 Without complications	0.000	0.573	0.427
E65-E68 Obesity and other hyperalimentation	0.000	0.575	0.425
E14 Unspecified diabetes mellitus	0.000	0.578	0.422
K90.4 Malabsorption due to intolerance, not elsewhere classified	0.000	0.580	0.420
K90.8 Other intestinal malabsorption	0.000	0.589	0.411
E44 Protein-energy malnutrition of moderate and mild degree	0.000	0.590	0.410
E45 Retarded development following protein-energy malnutrition	0.000	0.590	0.410
E43 Unspecified severe protein-energy malnutrition	0.000	0.590	0.410
E42 Marasmic kwashiorkor	0.000	0.590	0.410
E41 Nutritional marasmus	0.000	0.590	0.410
E40 Kwashiorkor	0.000	0.590	0.410
M07.37 Other psoriatic arthropathies (Ankle and foot)	0.410	0.590	0.000
T45.5 Anticoagulants	0.403	0.597	0.000
M07.38 Other psoriatic arthropathies (Other)	0.390	0.610	0.000
M07.35 Other psoriatic arthropathies (Pelvic region and thigh)	0.390	0.610	0.000
M07.33 Other psoriatic arthropathies (Forearm)	0.390	0.610	0.000
M07.32 Other psoriatic arthropathies (Upper arm)	0.390	0.610	0.000
M07.31 Other psoriatic arthropathies (Shoulder region)	0.390	0.610	0.000
E04.1 Non-toxic single thyroid nodule	0.000	0.643	0.357
E14.3 With ophthalmic complications	0.000	0.667	0.333
E20-E35 Disorders of other endocrine glands	0.000	0.672	0.328
Chapter XIX Injury, poisoning and certain other consequences of external causes	0.315	0.685	0.000
E07.8 Other specified disorders of thyroid	0.001	0.685	0.314
E67 Other hyperalimentation	0.000	0.695	0.304
E68 Sequelae of hyperalimentation	0.000	0.695	0.304
T20-T25 Burns and corrosions of external body surface, specified by site	0.303	0.697	0.000
E14.8 With unspecified complications	0.000	0.697	0.302
E14.7 With multiple complications	0.000	0.697	0.302
E14.6 With other specified complications	0.000	0.697	0.302
E14.2 Withrenal complications	0.000	0.697	0.302
E14.0 With coma	0.000	0.697	0.302
E27 Other disorders of adrenal gland	0.000	0.700	0.300
S80-S89 Injuries to the knee and lower leg	0.296	0.704	0.000
E14.4 With neurological complications	0.000	0.704	0.295
E44.1 Mild protein-energy malnutrition	0.000	0.706	0.294
E44.0 Moderate protein-energy malnutrition	0.000	0.706	0.294
S30-S39 Injuries to the abdomen, lower back, lumbar spine and pelvis	0.291	0.709	0.000
E27.1 Primary adrenocortical insufficiency	0.000	0.712	0.288
S82 Fracture of lower leg, including ankle	0.283	0.717	0.000
E14.5 With peripheral circulatory complications	0.000	0.723	0.276
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.274	0.725	0.001
S30 Superficial injury of abdomen, lower back and pelvis	0.269	0.731	0.000
E46 Unspecified protein-energy malnutrition	0.001	0.733	0.266
T22 Burn and corrosion of shoulder and upper limb, except wrist and hand	0.266	0.734	0.000
S82.1 Fracture of upper end of tibia	0.265	0.735	0.000
E04.2 Non-toxic multinodular goitre	0.000	0.738	0.262
E14.1 With ketoacidosis	0.000	0.738	0.262
T08-T14 Injuries to unspecified part of trunk, limb or body region	0.260	0.740	0.000
S82.5 Fracture of medial malleolus	0.258	0.742	0.000
S10-S19 Injuries to the neck	0.256	0.744	0.000
T25 Burn and corrosion of ankle and foot	0.255	0.745	0.000
S82.10 Fracture of upper end of tibia (closed)	0.251	0.749	0.000
T29-T32 Burns and corrosions of multiple and unspecified body regions	0.249	0.751	0.000
S82.6 Fracture of lateral malleolus	0.246	0.754	0.000
T15-T19 Effects of foreign body entering through natural orifice	0.246	0.754	0.000
E34 Other endocrine disorders	0.000	0.755	0.245
S30.8 Other superficial injuries of abdomen, lower back and pelvis	0.242	0.758	0.000
M07 Psoriatic and enteropathic arthropathies	0.239	0.760	0.002
S86 Injury of muscle and tendon at lower leg level	0.240	0.760	0.000
T20 Burn and corrosion of head and neck	0.240	0.760	0.000
S82.50 Fracture of medial malleolus (closed)	0.240	0.760	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.239	0.760	0.000
E24 Cushing's syndrome	0.000	0.761	0.239
T51-T65 Toxic effects of substances chiefly nonmedicinal as to source	0.237	0.763	0.000
T24 Burn and corrosion of hip and lower limb, except ankle and foot	0.235	0.764	0.000
E35 Disorders of endocrine glands in diseases classified elsewhere	0.000	0.764	0.235
E32 Diseases of thymus	0.000	0.764	0.235
E31 Polyglandular dysfunction	0.000	0.764	0.235
E30 Disorders of puberty, not elsewhere classified	0.000	0.764	0.235
E25 Adrenogenital disorders	0.000	0.764	0.235
T21 Burn and corrosion of trunk	0.234	0.766	0.000
E27.8 Other specified disorders of adrenal gland	0.000	0.767	0.233
S36 Injury of intra-abdominal organs	0.232	0.767	0.000
S30.2 Contusion of external genital organs	0.231	0.769	0.000
S31 Open wound of abdomen, lower back and pelvis	0.229	0.770	0.000
E27.2 Addisonian crisis	0.000	0.771	0.229
S82.0 Fracture of patella	0.228	0.772	0.000
T33-T35 Frostbite	0.226	0.774	0.000
T26-T28 Burns and corrosions confined to eye and internal organs	0.226	0.774	0.000
T66-T78 Other and unspecified effects of external causes	0.225	0.775	0.000
T00-T07 Injuries involving multiple body regions	0.225	0.775	0.000
T22.2 Burn of second degree of shoulder and upper limb, except wrist and hand	0.225	0.775	0.000
S81 Open wound of lower leg	0.223	0.777	0.000
T90-T98 Sequelae of injuries, of poisoning and of other consequences of external causes	0.222	0.778	0.000
S11 Open wound of neck	0.222	0.778	0.000
E28 Ovarian dysfunction	0.000	0.779	0.220
E29 Testicular dysfunction	0.000	0.780	0.220
S90-S99 Injuries to the ankle and foot	0.220	0.780	0.000
E65 Localised adiposity	0.000	0.780	0.220
S82.4 Fracture of fibula alone	0.220	0.780	0.000
S82.60 Fracture of lateral malleolus (closed)	0.220	0.780	0.000
T23 Burn and corrosion of wrist and hand	0.219	0.781	0.000
E67.8 Other specified hyperalimentation	0.000	0.781	0.218
E67.3 Hypervitaminosis D	0.000	0.781	0.218
E67.2 Megavitamin-B6 syndrome	0.000	0.781	0.218
E67.1 Hypercarotenaemia	0.000	0.781	0.218
E67.0 Hypervitaminosis A	0.000	0.781	0.218
L40-L45 Papulosquamous disorders	0.218	0.781	0.000
T22.3 Burn of third degree of shoulder and upper limb, except wrist and hand	0.218	0.781	0.000
S30.1 Contusion of abdominal wall	0.218	0.782	0.000
E27.5 Adrenomedullary hyperfunction	0.000	0.785	0.215
E27.3 Drug-induced adrenocortical insufficiency	0.000	0.785	0.215
E27.0 Other adrenocortical overactivity	0.000	0.785	0.215
T11 Other injuries of upper limb, level unspecified	0.213	0.787	0.000
S10 Superficial injury of neck	0.213	0.787	0.000
S88 Traumatic amputation of lower leg	0.212	0.788	0.000
S87 Crushing injury of lower leg	0.212	0.788	0.000
S85 Injury of blood vessels at lower leg level	0.212	0.788	0.000
S84 Injury of nerves at lower leg level	0.212	0.788	0.000
T25.0 Burn of unspecified degree of ankle and foot	0.212	0.788	0.000
S32 Fracture of lumbar spine and pelvis	0.211	0.789	0.000
T79-T79 Certain early complications of trauma	0.210	0.790	0.000
T09 Other injuries of spine and trunk, level unspecified	0.209	0.791	0.000
S38 Crushing injury and traumatic amputation of part of abdomen, lower back and pelvis	0.209	0.791	0.000
S35 Injury of blood vessels at abdomen, lower back and pelvis level	0.209	0.791	0.000
S34 Injury of nerves and lumbar spinal cord at abdomen, lower back and pelvis level	0.209	0.791	0.000
S33 Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis	0.209	0.791	0.000
T18 Foreign body in alimentary tract	0.208	0.792	0.000
E20 Hypoparathyroidism	0.000	0.794	0.206
S89 Other and unspecified injuries of lower leg	0.205	0.794	0.000
S82.9 Fracture of lower leg, part unspecified	0.203	0.797	0.000
S91 Open wound of ankle and foot	0.203	0.797	0.000
T31 Burns classified according to extent of body surface involved	0.201	0.799	0.000
T25.2 Burn of second degree of ankle and foot	0.199	0.800	0.000
E34.8 Other specified endocrine disorders	0.000	0.802	0.198
T20.2 Burn of second degree of head and neck	0.198	0.802	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.197	0.803	0.001
T40.8 Lysergide [LSD]	0.197	0.803	0.001
T40.7 Cannabis (derivatives)	0.197	0.803	0.001
T40.5 Cocaine	0.197	0.803	0.001
T40.3 Methadone	0.197	0.803	0.001
T40.1 Heroin	0.197	0.803	0.001
T40.0 Opium	0.197	0.803	0.001
T90 Sequelae of injuries of head	0.197	0.803	0.000
S80 Superficial injury of lower leg	0.196	0.804	0.000
S82.7 Multiple fractures of lower leg	0.195	0.805	0.000
T13 Other injuries of lower limb, level unspecified	0.194	0.806	0.000
S19 Other and unspecified injuries of neck	0.193	0.807	0.000
S30.7 Multiple superficial injuries of abdomen, lower back and pelvis	0.193	0.807	0.000
S86.9 Injury of unspecified muscle and tendon at lower leg level	0.192	0.808	0.000
S82.2 Fracture of shaft of tibia	0.192	0.808	0.000
S39 Other and unspecified injuries of abdomen, lower back and pelvis	0.192	0.808	0.000
S37 Injury of urinary and pelvic organs	0.192	0.808	0.000
S31.4 Open wound of vagina and vulva	0.191	0.808	0.000
E26 Hyperaldosteronism	0.000	0.809	0.191
T22.7 Corrosion of third degree of shoulder and upper limb, except wrist and hand	0.191	0.809	0.000
T22.6 Corrosion of second degree of shoulder and upper limb, except wrist and hand	0.191	0.809	0.000
T22.5 Corrosion of first degree of shoulder and upper limb, except wrist and hand	0.191	0.809	0.000
T22.4 Corrosion of unspecified degree of shoulder and upper limb, except wrist and hand	0.191	0.809	0.000
T22.1 Burn of first degree of shoulder and upper limb, except wrist and hand	0.191	0.809	0.000
T22.0 Burn of unspecified degree of shoulder and upper limb, except wrist and hand	0.191	0.809	0.000
S82.00 Fracture of patella (closed)	0.191	0.809	0.000
T51 Toxic effect of alcohol	0.191	0.809	0.000
T16 Foreign body in ear	0.190	0.810	0.000
S82.11 Fracture of upper end of tibia (open)	0.190	0.810	0.000
T21.3 Burn of third degree of trunk	0.189	0.811	0.000
S91.1 Open wound of toe(s) without damage to nail	0.189	0.811	0.000
E27.4 Other and unspecified adrenocortical insufficiency	0.000	0.811	0.188
E28.3 Primary ovarian failure	0.000	0.812	0.188
T24.2 Burn of second degree of hip and lower limb, except ankle and foot	0.187	0.813	0.000
E22 Hyperfunction of pituitary gland	0.000	0.813	0.187
S11.8 Open wound of other parts of neck	0.187	0.813	0.000
T12.X1 Fracture of lower limb, level unspecified (open)	0.187	0.813	0.000
T12.X0 Fracture of lower limb, level unspecified (closed)	0.187	0.813	0.000
T12 Fracture of lower limb, level unspecified	0.187	0.813	0.000
T10.X1 Fracture of upper limb, level unspecified (open)	0.187	0.813	0.000
T10.X0 Fracture of upper limb, level unspecified (closed)	0.187	0.813	0.000
T10 Fracture of upper limb, level unspecified	0.187	0.813	0.000
T08.X1 Fracture of spine, level unspecified (open)	0.187	0.813	0.000
T08.X0 Fracture of spine, level unspecified (closed)	0.187	0.813	0.000
T08 Fracture of spine, level unspecified	0.187	0.813	0.000
E70-E90 Metabolic disorders	0.000	0.813	0.187
S86.8 Injury of other muscles and tendons at lower leg level	0.186	0.813	0.000
S82.51 Fracture of medial malleolus (open)	0.185	0.815	0.000
E24.9 Cushing's syndrome, unspecified	0.000	0.815	0.185
T21.2 Burn of second degree of trunk	0.184	0.816	0.000
T56 Toxic effect of metals	0.183	0.816	0.000
S17 Crushing injury of neck	0.183	0.817	0.000
S15 Injury of blood vessels at neck level	0.183	0.817	0.000
S18 Traumatic amputation at neck level	0.183	0.817	0.000
S16 Injury of muscle and tendon at neck level	0.183	0.817	0.000
T25.7 Corrosion of third degree of ankle and foot	0.183	0.817	0.000
T25.6 Corrosion of second degree of ankle and foot	0.183	0.817	0.000
T25.5 Corrosion of first degree of ankle and foot	0.183	0.817	0.000
T25.4 Corrosion of unspecified degree of ankle and foot	0.183	0.817	0.000
T25.3 Burn of third degree of ankle and foot	0.183	0.817	0.000
T25.1 Burn of first degree of ankle and foot	0.183	0.817	0.000
E66 Obesity	0.000	0.817	0.183
S36.0 Injury of spleen	0.182	0.818	0.000
S10.9 Superficial injury of neck, part unspecified	0.182	0.818	0.000
T66 Unspecified effects of radiation	0.182	0.818	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations